<i>Letter to the Editor:</i> Repurposing Tafenoquine as a Potential Inhibitor Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease via a Fluorescence Polarization Assay-Reference-Cited by-同舟云学术

Letter to the Editor: Repurposing Tafenoquine as a Potential Inhibitor Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease via a Fluorescence Polarization Assay

Published:2023-12-01 Issue:8 Volume:21 Page:369-371
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Zhang Rui¹,Yan Haohao¹^ORCID,Yan Gangan¹,Liu Xiaoping¹,Chen Yunyu¹^ORCID

Affiliation:

1. Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/adt.2023.103

Reference6 articles.

1. Targeting SARS‐CoV‐2 viral proteases as a therapeutic strategy to treat COVID‐19

2. Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV

3. Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors

4. Protocol for high-throughput screening of SARS-CoV-2 main protease inhibitors using a robust fluorescence polarization assay

5. Production of a versatile SARS‐CoV‐2 main protease biosensor based on a dimerization‐dependent red fluorescent protein

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved fluorescence‐based assay for rapid screening and evaluation of SARS‐CoV‐2 main protease inhibitors;Journal of Medical Virology;2024-03

2. Evaluation of natural products from virtual screenings as SARS-CoV-2 main protease inhibitors using combinational experiments;Natural Product Research;2024-01-08